Here is the full list of the biotech and pharma Startup Battlefield 200 selectees, along with a note on what made us select ...
VESALIUS-CV was big in 2025, but studies looking at triglycerides, CRISPR, and oral GLP-1s also made the highlight reel.
The global prime editing and CRISPR market size was US$ 3,194.2 million in 2021. The global prime editing and CRISPR market is forecast to grow to US$ 17,618.4 million by 2030 by registering a ...
Zacks Small Cap Research on MSN
DYAI: Layers of commercialization agreements
The new arrangements were all announced in December and include a development and commercialization agreement signed with BRIG BIO, a commercial partnership with Opes Diagnostics and an expansion of ...
Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy ...
Precise tumor diagnosis and treatment require the support of abundant molecular information. However, conventional molecular ...
AZoLifeSciences on MSN
Tackling the world’s food-waste crisis
AI innovations and smart packaging are revolutionizing food waste reduction, driving sustainability and enhancing food ...
CRISPR biosensors enable real-time health monitoring with attomolar sensitivity, wearable integration, and multiplex ...
Inside cells, DNA twists and coils itself into a variety of different secondary structures—including i-motifs (iMs) and ...
Using X-ray diffraction data, James Watson (1928-2025) made the seminal discovery of the double-helical structure of DNA ...
Scientists from Kolkata-based Bose Institute have created GlowCas9 -- a CRISPR protein that lights up while performing gene editing -- to help boost treatment of genetic diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results